Who owns DERMATA THERAPEUTICS INC?
- Ticker: DRMA
- CUSIP Number: 249845504
Tip: Access positions for across all investors
Analyze quarterly positions in Dermata Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Dermata Therapeutics stock
Who bought or sold DERMATA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 20k | $26k | -58% | Jun 2026 |
|
| Welch & Forbes | 20k | $26k | 0% | Jun 2026 |
|
| UBS Group | 17k | $22k | -53% | Jun 2026 |
|
| Susquehanna International | 16k | $21k | 100% | Jun 2026 |
|
| XTX Topco | 15k | $19k | 100% | Jun 2026 |
|
| Advisory Alpha | 10k | $13k | 100% | Jun 2026 |
|
| Tower Research Capital | 3.9k | $5.0k | 439% | Jun 2026 |
|
| MCF Advisors | 1.7k | $2.2k | 0% | Jun 2026 |
|
| Barclays | 270.00 | $348.003000 | 100% | Jun 2026 |
|
| SBI Securities | 101.00 | $129.997100 | 0% | Jun 2026 |
|
| Highline Wealth Partners | 26.00 | $34.000200 | 100% | Jun 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|